Semler Scientific, Inc. financial data

Symbol
SMLR on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
2340 2348 Walsh Avenue, Suite 2344, Santa Clara, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 723 % +8.46%
Quick Ratio 6.39 % +16.2%
Return On Equity 20.3 % -34.4%
Return On Assets 18.8 % -31%
Operating Margin 29.6 % -38.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.27M shares +5.72%
Common Stock, Shares, Outstanding 7.12M shares +5.84%
Entity Public Float 115M USD -26%
Common Stock, Value, Issued 7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 7.05M shares +4.88%
Weighted Average Number of Shares Outstanding, Diluted 7.77M shares -0.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 13.5M USD -17.2%
Revenue from Contract with Customer, Excluding Assessed Tax 68.2M USD +20.3%
Cost of Revenue 7.04M USD +47.3%
Selling and Marketing Expense 14.7M USD -19.7%
General and Administrative Expense 12.2M USD -12.7%
Costs and Expenses 39M USD -10.4%
Operating Income (Loss) 19.9M USD -14.7%
Nonoperating Income (Expense) -1.79M USD -195%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 18.1M USD -28.2%
Income Tax Expense (Benefit) 2.21M USD -61%
Net Income (Loss) Attributable to Parent 15.9M USD -18.7%
Earnings Per Share, Basic 2.3 USD/shares -21.2%
Earnings Per Share, Diluted 2.04 USD/shares -18.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.57M USD -82.5%
Accounts Receivable, after Allowance for Credit Loss, Current 6.67M USD +11.8%
Inventory, Net 380K USD -13.4%
Assets, Current 21.5M USD -66.6%
Deferred Income Tax Assets, Net 3.32M USD +19.5%
Operating Lease, Right-of-Use Asset 87K USD -49.1%
Other Assets, Noncurrent 106K USD -96.1%
Assets 92.2M USD +16.1%
Accounts Payable, Current 545K USD +81.7%
Employee-related Liabilities, Current 3.04M USD -17%
Accrued Liabilities, Current 5.26M USD -24.9%
Contract with Customer, Liability, Current 805K USD -28.1%
Liabilities, Current 6.84M USD -20.3%
Operating Lease, Liability, Noncurrent 24K USD -79.3%
Other Liabilities, Noncurrent 24K USD -79.3%
Retained Earnings (Accumulated Deficit) 71.5M USD +28.6%
Stockholders' Equity Attributable to Parent 85.4M USD +20.6%
Liabilities and Equity 92.2M USD +16.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 5.62M USD +553%
Net Cash Provided by (Used in) Financing Activities 11K USD
Net Cash Provided by (Used in) Investing Activities -81K USD +99.6%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 7.33M shares +5.66%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.55M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.7M USD -82.1%
Deferred Tax Assets, Valuation Allowance 936K USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 3M USD +27.3%
Operating Lease, Liability 93K USD -48.9%
Depreciation 46K USD +6.98%
Payments to Acquire Property, Plant, and Equipment 4K USD -95.8%
Lessee, Operating Lease, Liability, to be Paid 95K USD -49.2%
Operating Lease, Liability, Current 93K USD +5.68%
Lessee, Operating Lease, Liability, to be Paid, Year Two 71K USD -23.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 71K USD -23.7%
Deferred Income Tax Expense (Benefit) -136K USD -70%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2K USD -60%
Lessee, Operating Lease, Liability, to be Paid, Year Three 71K USD -23.7%
Deferred Tax Assets, Operating Loss Carryforwards 188K USD -38%
Unrecognized Tax Benefits 582K USD +18.1%
Additional Paid in Capital 13.9M USD -8.77%
Deferred Tax Assets, Net of Valuation Allowance 3M USD +27.3%
Share-based Payment Arrangement, Expense 535K USD -43.1%